- Anoro preparatomtale
- Donohue JF, Singh D, Munzu C et al. Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trials. Respir Med 2016; 112: 65−74.
- Maleki-Yazdi MR et al. Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: results of a 24-week, randomized, controlled trial. Respir Med 2014; 108(12):1752-1760.
- Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (2017) © 2017 Global Initiative for Chronic Obstructive Lung Disease, all rights reserved. Use is by express license from the owner. www.goldcopd.org (Last accessed November 2016).
- van der Palen J, Thomas M, Chrystyn H et al. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices. Prim Care Respir J 2016; (26)16079; doi:10.1038/npjpcrm.2016.79